<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

	<!-- RSS feed defaults -->
	<channel>
		<title>Wyss InstituteInfectious Disease &#8211; Wyss Institute</title>
		<link>https://wyss.harvard.edu</link>
		<description>Wyss Institute at Harvard</description>
		<lastBuildDate>Wed, 29 Apr 2026 19:21:07 +0000</lastBuildDate>
		<language>en-US</language>
		<sy:updatePeriod>hourly</sy:updatePeriod>
		<sy:updateFrequency>1</sy:updateFrequency>
		<atom:link href="https://wyss.harvard.edu/application-area/infectious-disease/feed/" rel="self" type="application/rss+xml" />

		<generator>https://wordpress.org/?v=6.7.1</generator>

		<!-- Start loop -->
		
			<item>
				<title>James Collins: Doing Good Science with an Underdog Spirit &#8211; The Pulse Podcast</title>
				<link>https://wyss.harvard.edu/media-post/james-collins-doing-good-science-with-an-underdog-spirit-the-pulse-podcast/</link>
        <pubDate>Mon, 16 Mar 2026 17:11:57 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Antibiotic Resistance]]></category>
		<category><![CDATA[Antibiotics]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[James J. Collins]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=45078</guid>
                                                <content:encoded><![CDATA[<p>James J. Collins is a founding Core Faculty member at the Wyss Institute and the Termeer Professor of Medical Engineering &amp; Science and Professor of Biological Engineering at MIT. Jim serves as a director at the MIT Jameel Clinic, a member of the Harvard&#x2d;MIT Health Sciences &amp; Technology Faculty, and a member of the Broad Institute. Jim is also an elected member of all three national academies.</p>
<p><a href="https://wyss.harvard.edu/media-post/james-collins-doing-good-science-with-an-underdog-spirit-the-pulse-podcast/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/james-collins-doing-good-science-with-an-underdog-spirit-the-pulse-podcast/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2016/08/05170306/375x265_0020_19-James-J.-Collins-headshot-004-3-e1550782188188.png?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=7a0f636fee2bde2fd0bfa3c5752f4086"/></url>
				</image>
        			</item>

		
			<item>
				<title>Building protection against infectious diseases with nanostructured vaccines</title>
				<link>https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/</link>
        <pubDate>Wed, 11 Mar 2026 12:56:44 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Dana-Farber Cancer Institute]]></category>
		<category><![CDATA[DNA assembly]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Technology Translation]]></category>
		<category><![CDATA[William Shih]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=45012</guid>
                            <description>Wyss Institute’s DoriVac combined vaccine and adjuvant technology uses nanoscale precision enabled by DNA origami to induce broad immunity against infectious viruses</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; The COVID&#x2d;19 pandemic brought messenger RNA (mRNA) vaccines to the forefront of global health care. After their clinical trial stages, the first COVID&#x2d;19 mRNA vaccine was administered on 8 December 2020 and mathematical models suggest that mRNA vaccines prevented at least 14.4 million deaths from COVID&#x2d;19 in the first year alone.</p>
<p><a href="https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/building-protection-against-infectious-diseases-with-nanostructured-vaccines/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2022/10/19140258/banner-image-DoriVac.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=02c46a8a5e23e0c41c361cb65f4eb81c"/></url>
				</image>
        			</item>

		
			<item>
				<title>Namrata Ramani on sculpting the future of delivering novel cancer therapeutics</title>
				<link>https://wyss.harvard.edu/news/humans-of-the-wyss-namrata-ramani-on-sculpting-the-future-of-delivering-novel-cancer-therapeutics/</link>
        <pubDate>Fri, 27 Feb 2026 18:32:49 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Community]]></category>
		<category><![CDATA[ARPA-H]]></category>
		<category><![CDATA[Drug Delivery]]></category>
		<category><![CDATA[Humans of the Wyss]]></category>
		<category><![CDATA[RNA]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44843</guid>
                                                <content:encoded><![CDATA[<p>The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. What do pottery and materials science have in common? Namrata Ramani used to think they were worlds apart. Then, as she honed her skills on the wheel and at the bench, she realized there are&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/humans-of-the-wyss-namrata-ramani-on-sculpting-the-future-of-delivering-novel-cancer-therapeutics/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/humans-of-the-wyss-namrata-ramani-on-sculpting-the-future-of-delivering-novel-cancer-therapeutics/</link>
          <title>Namrata Ramani, Postdoctoral Fellow. Credit: Wyss Institute at Harvard University</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2026/02/27133110/HoW-Namrata-Ramani-08080-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=851704bc882329dc9f271a908cbdf893"/></url>
				</image>
        			</item>

		
			<item>
				<title>A CRISPR fingerprint of pathogenic C. auris fungi</title>
				<link>https://wyss.harvard.edu/news/a-crispr-fingerprint-of-pathogenic-c-auris-fungi/</link>
        <pubDate>Wed, 14 Jan 2026 13:45:36 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Antibiotic Resistance]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Brigham and Women's Hospital]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[David R. Walt]]></category>
		<category><![CDATA[DNA synthesis]]></category>
		<category><![CDATA[Fungi]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[James J. Collins]]></category>
		<category><![CDATA[MIT]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=44495</guid>
                            <description>Precision diagnostic platform integrating CRISPR and single-molecule technology with AI enables rapid and accurate detection of drug-resistant <em>C. auris</em> pathogens</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Infection with the pathogenic yeast fungus Candida auris (C. auris) can wreak havoc on the health of hospital patients and residents of nursing homes, especially those who are already weakened by other illnesses. The pathogen easily spreads and colonizes surfaces and objects where it can survive for weeks to months, and is often resistant to standard&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/a-crispr-fingerprint-of-pathogenic-c-auris-fungi/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/a-crispr-fingerprint-of-pathogenic-c-auris-fungi/</link>
          <title>Candida auris is a pathogenic yeast that cannot be rapidly diagnosed using common methods. Neither can antifungal resistances, which together presents a pressing unmet medical need. Creidt: peterschreiber.media</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/12/19132316/iStock-2152049869-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=1a83c0b2d2fc7ae17d41676ada01320e"/></url>
				</image>
        			</item>

		
			<item>
				<title>Biomaterial vaccines to make implanted orthopedic devices safer</title>
				<link>https://wyss.harvard.edu/news/biomaterial-vaccines-to-make-implanted-orthopedic-devices-safer/</link>
        <pubDate>Mon, 03 Nov 2025 19:55:42 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Antibiotic Resistance]]></category>
		<category><![CDATA[Biofilm]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[David J. Mooney]]></category>
		<category><![CDATA[Harvard SEAS]]></category>
		<category><![CDATA[Immune System]]></category>
		<category><![CDATA[Implants]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=42430</guid>
                            <description>Biomaterial vaccines using pathogen-specific antigens could significantly lower patients’ risk of infection from implanted medical devices</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; Patients with implanted medical devices like orthopedic joint replacements, pacemakers, and artificial heart valves run a small but significant risk that these devices get infected with bacterial pathogens. This starts them on a burdensome path requiring &ldquo;redo&rdquo; (revision) surgeries, prolonged antibiotic treatments, or in severe cases amputation.</p>
<p><a href="https://wyss.harvard.edu/news/biomaterial-vaccines-to-make-implanted-orthopedic-devices-safer/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/biomaterial-vaccines-to-make-implanted-orthopedic-devices-safer/</link>
          <title>A team at Harvard’s Wyss Institute and SEAS has developed a novel vaccine strategy with the potential to solve the challenge of device infection in patients. Applied to a mouse model of orthopedic device infection, the vaccines worked 100-fold more effectively than much shorter-lived conventional control vaccines. Credit: Envato Elements/chormail</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/04/08130211/4b9ffa17-ce35-4435-855f-8c1b68be5db7-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=e8efe22d2194387a73b659b03ac0598b"/></url>
				</image>
        			</item>

		
			<item>
				<title>Human Organ Chip technology sets stage for pan-influenza A CRISPR RNA therapies</title>
				<link>https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/</link>
        <pubDate>Wed, 15 Oct 2025 13:55:54 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Biomedical Engineering]]></category>
		<category><![CDATA[Biomimetic Microsystems]]></category>
		<category><![CDATA[CRISPR]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Gene Expression]]></category>
		<category><![CDATA[Harvard Medical School]]></category>
		<category><![CDATA[Influenza]]></category>
		<category><![CDATA[Lung-on-a-chip]]></category>
		<category><![CDATA[Nanoparticles]]></category>
		<category><![CDATA[Natalie Artzi]]></category>
		<category><![CDATA[Pathogen]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43920</guid>
                            <description>Human lung alveolus chip infection model enables investigation of viral replication, inflammatory responses, and genetic off-target effects of a novel pan-influenza CRISPR therapy</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &ndash; The Influenza A virus (IAV) has been the cause of six major flu pandemics, responsible for 50 to 100 million deaths globally. In the U.S. alone, it is estimated that, despite seasonally updated vaccines, IAV infections still lead to 140,000 to 710,000 hospitalizations and 12,000 to 52,000 deaths annually. The development of antiviral treatments against IAV&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/human-organ-chip-technology-sets-stage-for-pan-influenza-a-crispr-rna-therapies/</link>
          <title>New findings show that future pan-influenza A vaccines based on CRISPR technology can be preclinically assessed in human Organ Chips. Credit: Envato Elements/dvatri</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/10/14105510/portrait-of-a-family-activities-at-home-2025-09-14-16-44-58-utc-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c1f3463c4436feb34fe1078d4163cfb9"/></url>
				</image>
        			</item>

		
			<item>
				<title>Engineering Living Materials with Peter Q. Nguyen</title>
				<link>https://wyss.harvard.edu/media-post/engineering-living-materials-with-peter-q-nguyen/</link>
        <pubDate>Wed, 24 Sep 2025 16:13:25 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=43762</guid>
                                                <content:encoded><![CDATA[<p>In this episode of the CoreSpin Podcast Interview Series, host Misha Bagirov sits down with Wyss Senior Scientist Peter Q. Nguyen, Ph.D., to explore how synthetic biology can turn biofilms into useful materials, embed cell&#x2d;free systems into wearables (like COVID&#x2d;sensing masks), and program probiotics as future therapeutics. We also talked about the philosophy behind bioengineering&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/engineering-living-materials-with-peter-q-nguyen/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/engineering-living-materials-with-peter-q-nguyen/</link>
          <title>Peter Nguyen, Research Scientist - Microbiology and Cellular Devices. Credit: Wyss Institute at Harvard University </title>
					<url>https://wyss-prod.imgix.net/app/uploads/2021/09/05104106/HoW-Peter-Nguyen-0211.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=c318ebe4c5262e0579828f524b94e49f"/></url>
				</image>
        			</item>

		
			<item>
				<title>Can We Stop Stabbing Babies? &#8211; Salivary Diagnostics for Sepsis Screening in the Neonate</title>
				<link>https://wyss.harvard.edu/media-post/can-we-stop-stabbing-babies-salivary-diagnostics-for-sepsis-screening-in-the-neonate/</link>
        <pubDate>Wed, 10 Sep 2025 20:51:39 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[Machine Learning]]></category>
		<category><![CDATA[Translational AI Catalyst]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=media_post&#038;p=43645</guid>
                                                <content:encoded><![CDATA[<p>Every day, across the neonatal care unit, babies are being stabbed to collect their blood for sepsis tests. Adding to this dismal situation, diagnostics developed to assess sepsis in blood are very inaccurate, leading to the unnecessary prescription of antibiotics. Researchers at the Wyss Institute and Brigham and Women&rsquo;s Hospital have created a more accurate diagnostic platform using easily&#8230;</p>
<p><a href="https://wyss.harvard.edu/media-post/can-we-stop-stabbing-babies-salivary-diagnostics-for-sepsis-screening-in-the-neonate/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/media-post/can-we-stop-stabbing-babies-salivary-diagnostics-for-sepsis-screening-in-the-neonate/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/09/10164856/THUMBNAIL-Can-We-Stop-Stabbing-Babies_No-Text-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=01cf66340268c4045b3a0b385928534b"/></url>
				</image>
        			</item>

		
			<item>
				<title>NeoSense: Sepsis Detection in Newborns</title>
				<link>https://wyss.harvard.edu/technology/neosense-sepsis-detection-in-newborns/</link>
        <pubDate>Tue, 05 Aug 2025 15:54:38 +0000</pubDate>
        <dc:creator><![CDATA[Mariel Schoen]]></dc:creator>
        		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[David R. Walt]]></category>
		<category><![CDATA[Machine Learning]]></category>
		<category><![CDATA[Translational AI Catalyst]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?post_type=technology&#038;p=43038</guid>
                                                <content:encoded><![CDATA[<p>Sepsis is a life&#x2d;threatening condition, and the third leading cause of neonatal mortality worldwide. In the U.S., there are about 1.75M suspected cases each year, accounting for 60% of NICU admissions. Current sepsis diagnostics rely on painful blood draws that can take days to deliver results &ndash; often leading to unnecessary antibiotic use. To address this challenge, we&rsquo;re creating NeoSense&#8230;</p>
<p><a href="https://wyss.harvard.edu/technology/neosense-sepsis-detection-in-newborns/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/technology/neosense-sepsis-detection-in-newborns/</link>
          <title></title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/07/17133155/a-baby-girl-with-her-hands-covering-her-mouth-loo-2025-04-03-17-58-24-utc-1.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=418ad96ccd4dc4af350c731f0d6381f4"/></url>
				</image>
        			</item>

		
			<item>
				<title>Broad-spectrum coronavirus drug developed through AI-enabled dynamic modeling</title>
				<link>https://wyss.harvard.edu/news/broad-spectrum-coronavirus-drug-developed-through-ai-enabled-dynamic-modeling/</link>
        <pubDate>Thu, 12 Jun 2025 14:55:26 +0000</pubDate>
        <dc:creator><![CDATA[Jessica Leff]]></dc:creator>
        		<category><![CDATA[Press Releases]]></category>
		<category><![CDATA[Artificial Intelligence]]></category>
		<category><![CDATA[COVID-19]]></category>
		<category><![CDATA[Donald E. Ingber]]></category>
		<category><![CDATA[Virus]]></category>
				<guid isPermaLink="false">https://wyss.harvard.edu/?p=43004</guid>
                            <description>Multidisciplinary AI- and physics-driven modeling of the viral fusion process enables discovery of an orally available drug inhibiting infection with multiple coronaviruses</description>
                                        <content:encoded><![CDATA[<p>By Benjamin Boettner (BOSTON) &mdash; About 30% of all respiratory tract infections are caused by coronaviruses, leading to widespread illnesses and, in some cases, to epidemic and even pandemic outbreaks, as we experienced with the COVID&#x2d;19 pandemic. Despite the development of groundbreaking technology that enables the design of prophylactic vaccines, access to those vaccines is not equal across&#8230;</p>
<p><a href="https://wyss.harvard.edu/news/broad-spectrum-coronavirus-drug-developed-through-ai-enabled-dynamic-modeling/" rel="nofollow">Source</a></p>]]></content:encoded>
                                    
				<image>
          <link>https://wyss.harvard.edu/news/broad-spectrum-coronavirus-drug-developed-through-ai-enabled-dynamic-modeling/</link>
          <title>Through powerful AI- and physics-driven modeling of the viral fusion process that the Spike protein on the virus surface is key to, as well as subsequent drug prediction and development efforts, the team identified a promising new broad-spectrum coronavirus drug that could be used in future respiratory pandemics, even as a prophylactic treatment. Credit: Envato</title>
					<url>https://wyss-prod.imgix.net/app/uploads/2025/06/11125616/coronavirus-covid-19-1-scaled.jpg?auto=format%2Ccompress&#038;crop=faces%2Centropy&#038;fit=crop&#038;h=400&#038;q=50&#038;w=300&#038;s=6efb5227f8f3e30b58ef2651a624457f"/></url>
				</image>
        			</item>

			</channel>
</rss>
